Literature DB >> 19897496

Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score.

Ronen Rubinshtein1, Eric H Yang, Charanjit S Rihal, Abhiram Prasad, Ryan J Lennon, Patricia J Best, Lilach O Lerman, Amir Lerman.   

Abstract

AIMS: The study aim was to evaluate the relation between the Framingham risk score (FRS) and the presence of coronary risk factors to coronary microcirculatory vasodilator function in patients with early coronary atherosclerosis. METHODS AND
RESULTS: We evaluated 1063 patients (age: 50 +/- 12 years, 676 (64%) females) without significant narrowing (<30%) on coronary angiography who underwent invasive assessment of coronary endothelial function. Coronary blood flow (CBF) in response to the endothelium-dependent vasodilator acetylcholine was evaluated as well as the microvascular (endothelium-independent) coronary flow reserve (CFR) in response to intracoronary adenosine. Coronary blood flow and CFR were analysed in relation to the FRS and the presence of traditional and novel risk factors. The estimated 10 years risk in this group was 5.4 +/- 5.2%. Higher FRS was associated with lower CBF in men (P = 0.008), and was a univariate predictor of lower CFR (P = 0.012) in all patients. Multivariable analysis identified a higher FRS (P < 0.001), female sex (P < 0.001) and a positive family history of coronary disease (P = 0.043) as independent predictors of reduced CFR.
CONCLUSION: In patients without obstructive coronary disease, a higher FRS was an independent predictor of reduced CFR. The current study provides insight into the relation between cardiac risk profile and coronary microcirculatory function, and suggests that impaired microcirculatory vasodilator function may be present even in patients with a low to intermediate Framingham score.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897496      PMCID: PMC2854505          DOI: 10.1093/eurheartj/ehp459

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  34 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic.

Authors:  Robert O Bonow; Lynn A Smaha; Sidney C Smith; George A Mensah; Claude Lenfant
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

3.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

4.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

5.  Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; M di Terlizzi; K P Schäfers; T F Lüscher; P G Camici
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

6.  Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; K P Schäfers; T F Lüscher; P G Camici
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

7.  Prognostic value of coronary vascular endothelial dysfunction.

Authors:  Julian P J Halcox; William H Schenke; Gloria Zalos; Rita Mincemoyer; Abhiram Prasad; Myron A Waclawiw; Khaled R A Nour; Arshed A Quyyumi
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

8.  Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  B Delia Johnson; Leslee J Shaw; Steven D Buchthal; C Noel Bairey Merz; Hee-Won Kim; Katherine N Scott; Mark Doyle; Marian B Olson; Carl J Pepine; Jan den Hollander; Barry Sharaf; William J Rogers; Sunil Mankad; John R Forder; Sheryl F Kelsey; Gerald M Pohost
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

9.  Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events.

Authors:  Paul V Targonski; Piero O Bonetti; Geralyn M Pumper; Stuart T Higano; David R Holmes; Amir Lerman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 10.  A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings.

Authors:  Axel R Pries; Helmut Habazettl; Giuseppe Ambrosio; Peter Riis Hansen; Juan Carlos Kaski; Volker Schächinger; Harald Tillmanns; Giuseppe Vassalli; Isabella Tritto; Michael Weis; Cor de Wit; Raffaele Bugiardini
Journal:  Cardiovasc Res       Date:  2008-05-29       Impact factor: 10.787

View more
  26 in total

1.  Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses.

Authors:  Martin Reriani; Andreas J Flammer; Jing Li; Megha Prasad; Charanjit Rihal; Abhiram Prasad; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-11       Impact factor: 1.439

2.  Vascular function of the peripheral and coronary circulation: worthwhile to assess their relation?

Authors:  Ines Valenta; Ulf Landmesser; Thomas H Schindler
Journal:  J Nucl Cardiol       Date:  2011-04       Impact factor: 5.952

3.  Effect of lifelong football training on the expression of muscle molecular markers involved in healthy longevity.

Authors:  A Mancini; D Vitucci; G Labruna; E Imperlini; M B Randers; J F Schmidt; M Hagman; T R Andersen; R Russo; S Orrù; P Krustrup; F Salvatore; P Buono
Journal:  Eur J Appl Physiol       Date:  2017-03-01       Impact factor: 3.078

4.  Early changes in myocardial microcirculation in asymptomatic hypercholesterolemic subjects: as detected by perfusion CT.

Authors:  Thomas R Behrenbeck; Cynthia H McCollough; Wayne L Miller; Eric E Williamson; Shuai Leng; Timothy L Kline; Erik L Ritman
Journal:  Ann Biomed Eng       Date:  2014-03       Impact factor: 3.934

Review 5.  Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Terrence D Ruddy; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

6.  Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy).

Authors:  Sandeep M Patel; Amir Lerman; Ryan J Lennon; Abhiram Prasad
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

7.  Coronary microvascular function in patients with Cushing's syndrome.

Authors:  Francesco Fallo; Giulia Famoso; Dario Capizzi; Nicoletta Sonino; Francesca Dassie; Pietro Maffei; Chiara Martini; Agostino Paoletta; Sabino Iliceto; Francesco Tona
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

Review 8.  The Human Microcirculation: Regulation of Flow and Beyond.

Authors:  David D Gutterman; Dawid S Chabowski; Andrew O Kadlec; Matthew J Durand; Julie K Freed; Karima Ait-Aissa; Andreas M Beyer
Journal:  Circ Res       Date:  2016-01-08       Impact factor: 17.367

Review 9.  Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease.

Authors:  Hassan Allaqaband; David D Gutterman; Andrew O Kadlec
Journal:  Physiology (Bethesda)       Date:  2018-09-01

10.  Personalized medicine in cardiovascular diseases.

Authors:  Moo-Sik Lee; Andreas J Flammer; Lilach O Lerman; Amir Lerman
Journal:  Korean Circ J       Date:  2012-09-27       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.